El-Nakeep Sarah, Madala Samragnyi, Chidharla Anusha, Surapaneni Balarama Krishna, Saha Subhrajit, Martin Benjamin, Kasi Anup
Faculty of Medicine, Ain Shams University, Cairo, Egypt.
University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA, United States; 52242.
Arch Intern Med Res. 2024;7(1):1-11. doi: 10.26502/aimr.0160. Epub 2024 Jan 20.
Radical excision (RE) for rectal cancer carries a higher risk of mortality and morbidity, while local excision (LE) could decrease these postoperative risks. However, the long-term benefit of LE is still debatable.
To study the effectiveness of LE versus RE in T1 and T2 rectal cancer.
A systematic review and meta-analysis was conducted using key databases like PubMed and ClinicalTrials.gov. Only cohort studies and randomized controlled trials were included. RevMan 5.4 tool was used for data analysis. Both clinical and statistical heterogeneity of the studies were assessed, and I >75% was considered as highly heterogeneous. The primary outcomes being measured were 5-year overall survival (OS) and 5-year disease free survival (DFS). A subgroup analysis of patients with T1-only was also conducted, without adjuvant chemo/radiotherapy.
A total of 18 studies were included for final meta-analysis. Four were RCTs, while the other 15 were retrospective cohort studies. One included study had data from both RCT and non-RCT study groups. Nine studies were multicentered or national studies while nine were unicentral.There was no difference in risk ratio (RR) between OS: RR 0.95, 95% Confidence Interval (CI) [0.91, 0.99] and DFS: RR 0.93, 95% CI [0.87, 1.01]. There were lower hazards ratios in OS: RR 1.41, 95% CI [1.14, 1.74] and DFS: RR 1.95, 95% CI [1.36, 2.78] with radical, as compared to LE. Lower recurrence rate was associated with RE. Random effect model was used due to clinical heterogeneity between studies (different surgical procedures, tumor staging, adjuvant chemo or radiotherapy).
LE for early-stage rectal cancer has lower 5-year OS and DFS than RE, with higher local recurrence rate. However, LE is associated with lower early postoperative mortality, morbidity and length of stay as compared to RE.
直肠癌根治性切除术(RE)的死亡率和发病率风险较高,而局部切除术(LE)可降低这些术后风险。然而,LE的长期益处仍存在争议。
研究LE与RE治疗T1和T2期直肠癌的有效性。
使用PubMed和ClinicalTrials.gov等关键数据库进行系统评价和荟萃分析。仅纳入队列研究和随机对照试验。使用RevMan 5.4工具进行数据分析。评估研究的临床和统计学异质性,I>75%被认为是高度异质性。测量的主要结局是5年总生存率(OS)和5年无病生存率(DFS)。还对仅T1期且未接受辅助化疗/放疗的患者进行了亚组分析。
共纳入18项研究进行最终荟萃分析。4项为随机对照试验,其他15项为回顾性队列研究。1项纳入研究同时有随机对照试验和非随机对照试验研究组的数据。9项研究为多中心或全国性研究,9项为单中心研究。OS的风险比(RR)无差异:RR 0.95,95%置信区间(CI)[0.91,0.99];DFS的风险比:RR 0.93,95%CI[0.87,1.01]。与LE相比,根治性手术在OS中的风险比更低:RR 1.41,95%CI[1.14,1.74];DFS中的风险比:RR 1.95,95%CI[1.36,2.78]。较低的复发率与RE相关。由于研究之间存在临床异质性(不同的手术方式、肿瘤分期、辅助化疗或放疗),使用随机效应模型。
早期直肠癌LE的5年OS和DFS低于RE,局部复发率更高。然而,与RE相比,LE术后早期死亡率、发病率和住院时间更低。